ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

STRO Sutro Biopharma Inc

4.20
0.12 (2.94%)
May 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 528,017
Bid Price 3.25
Ask Price 4.36
News -
Day High 4.24

Low
2.005

52 Week Range

High
6.13

Day Low 4.035
Share Name Share Symbol Market Stock Type
Sutro Biopharma Inc STRO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.12 2.94% 4.20 23:00:00
Open Price Low Price High Price Close Price Previous Close
4.15 4.035 4.24 4.14 4.08
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
4,548 528,017 US$ 4.14 US$ 2,186,548 - 2.005 - 6.13
Last Trade Type Quantity Price Currency
18:57:32 formt 1,028 US$ 4.20 USD

Sutro Biopharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
252.96M 60.95M - 153.73M -106.79M -1.75 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sutro Biopharma News

Date Time Source News Article
5/17/202416:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
5/13/202415:34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202415:30Edgar (US Regulatory)Form 8-K - Current report
5/13/202415:30GlobeNewswire Inc.Sutro Biopharma Reports First Quarter 2024 Financial..
4/30/202407:00GlobeNewswire Inc.Sutro Biopharma Announces Initiation of Randomized Portion..
4/02/202405:18GlobeNewswire Inc.Sutro Biopharma Announces Pricing of $75 Million..
3/25/202415:30GlobeNewswire Inc.Sutro Biopharma Reports Full Year 2023 Financial Results,..
3/07/202415:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No STRO Message Board. Create One! See More Posts on STRO Message Board See More Message Board Posts

Historical STRO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.185.08953.994.511,634,1850.020.48%
1 Month3.415.08953.3454.23874,1360.7923.17%
3 Months4.946.133.204.411,071,770-0.74-14.98%
6 Months2.556.132.134.22944,7971.6564.71%
1 Year5.276.132.0054.12730,442-1.07-20.30%
3 Years18.3723.702.0056.82571,785-14.17-77.14%
5 Years10.3828.302.0059.24438,197-6.18-59.54%

Sutro Biopharma Description

Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Your Recent History

Delayed Upgrade Clock